Cognistem Biosciences, LLC
Cenna Biosciences, LLC, based in La Jolla, California, is a biopharmaceutical company dedicated to developing innovative treatments for Alzheimer's disease. Their lead product, Nubytide, is a potential disease-modifying peptide offering a proactive therapy aimed at preventing and treating Alzheimer's, targeting inflammation and Tau pathology in the brain.
With a strong intellectual property portfolio and significant market potential, Cenna aims to make Nubytide accessible to every patient suffering from Alzheimer's disease. The company has received a Phase II SBIR grant from the National Institutes of Health to support the early clinical development of Nubytide, highlighting its commitment to addressing the growing global Alzheimer's epidemic.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.